Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001477845-16-000003
Filing Date
2016-10-26
Accepted
2016-10-26 16:19:48
Documents
1
Effectiveness Date
2016-10-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8232
  Complete submission text file 0001477845-16-000003.txt   9259
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
QR Pharma, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-273262 | Film No.: 161952831